Management Reports on BioPortfolio by title 201-300

• Management Reports on BioPortfolio by title 1-100
• Management Reports on BioPortfolio by title 101-200
• Management Reports on BioPortfolio by title 201-300
• Management Reports on BioPortfolio by title 301-400
• Management Reports on BioPortfolio by title 401-500
• Management Reports on BioPortfolio by title 501-600

If the link is not shown please go to the following page and use the search function:

http://www.bioportfolio.com/cgi-bin/acatalog/search.html

Click title to view report description:

HIV Related Neuropathic Pain - Useful Niche for Peripheral Companies
Food Allergies: New Treatments Are Nothing To Sneeze At
Commercial Insight: Osteoarthritis & Rheumatoid Arthritis - New Growth In A Mature Market
Current and Future Diabetes Blockbusters: Non-injected Insulins- Hype, Hope or Reality?
Licensing in Antibacterial R&D - Filling the Gaps
Commercial Insight: Antibacterials - Death of the Blockbuster?
Stakeholder Opinions: HIV - Reaching the 'Untapped' Patient Population
Stakeholder Opinions: HIV/HCV Co-infection - Whose Niche?
Antivirals-A broad market overview
Licensing & Partnerships in the Vaccine Field - The Fuel for Market Growth
Antiinfectives and Patent Expiries - A Cheap Fix
Pipeline Perspectives: Vaccines - Expanding Portfolio Diversity
Strategic Perspectives: Vaccines - Optimum Growth in a Crowded Market Place
Tropical Infections: A Status Update
Commercial Insight: HIV in the USA - Increasing Choice, Flexibility and Competition
Superficial Fungal Infections. Brand Awareness - the key to success?
Pipeline Perspectives: Hepatitis B & C - Antivirals Challenge the Interferons?
Bacterial Infections: An Epidemiological Overview
Market Dynamics: HIV - Combating a Market Slowdown
Commercial Perspectives: Pegylated Interferons - Leading the Way in HCV Therapy?
Stakeholder Insight: The Hospital Antibacterial Market - Specialist Products Drive Market Growth
HIV Resistance: Impact and Evolution
Strategic Perspectives: Invasive Fungal Infections - Cancidas and Vfend drive physician switching
Drugs of Tomorrow: HIV - Managing Portfolio Growth During Sector Slowdown
HIV Pricing Strategies in the US and UK
The Sepsis Market 2003 - Can Analyst Expectation be Met?
Pipeline Insight: Antibacterials - Select Classes, Select Uses
Key ID market events 2002
Fluoroquinolones - Established Products Drive Market Growth
Stakeholder Opinions: HIV/ HBV Co-infection - More Potency, More Policy
Invasive Fungal Infections - Options Outweigh Replacements
Vaccines - Nosocomial Pathogens
Human Papillomavirus - Vaccines, Then Antivirals?
Licensing Strategies: Benchmarking Analysis of The Top 20 Pharmaceutical Companies
Pharmaceutical Sales Forces: Benchmarking sales force management by geographical market and product lifecycle
Pharmaceuticals: Survival of the 'Fittest' - Can Competitive Advantage be Sustained Without M&A in the Wake of Pfizer/Pharmacia?
The Mid-Cap Japanese Pharmaceutical Sector: Evolving to Survive in the Face of Rising Competition
Regional Sales 2002: A Company and Therapeutic Market Analysis
Global Generics Guide 2nd Edition: Optimizing geographical and strategic positioning in an evolving generics landscape
Improving Sales Force Effectiveness: Evaluating the ROI of technology solutions in the pharmaceutical industry
Optimizing the Clinical Trial Process: Strategies to Reduce Costs and Increase Quality
European Market Entry Strategies: Impact of Regulations, Pricing, Reimbursement, Parallel Trade and Generics Post-Accession
US Hip and Knee Replacement - Market surges in new millennium
Commercial Perspectives: European Orthopaedics - Hips and Knees Bearing Market Load
Stakeholder Opinions: Minimally Invasive Hip and Knee Replacement - Excitement Winning Out Over Skepticism
Spinal Compression Repair: Surgeon interest in kyphoplasty balloons
Stakeholder Opinions: Spinal Disc Replacement - Market Expects, But Will Surgeons Deliver?
Stakeholder Opinions: Minimally Invasive Spinal Surgery - Surgeons Await Helping Hand from Manufacturers
Treatment of Elderly Cancer Patients - An Untapped Market Opportunity
Pipeline Insight: Prostate Cancer - Domination By The Innovative Classes
Stakeholder Insight: Hormonal Therapies in Breast Cancer
Stakeholder Insight: Breast Cancer Chemotherapy
Stakeholder Insight: Adjunct Therapies in Breast Cancer
Stakeholder Insight: Herceptin, The First of the Innovative Therapies
Stakeholder Insight: The Screening and Diagnosis of Breast Cancer
Benign Prostatic Hyperplasia: Expanding the drug treated population
Pipeline Insight: Innovatives Therapies - Diversification and Expansion of the Innovatives Class Driving the Evolution of Cancer Treatment
Pipeline Insight: Immunostimulators: Diversification and expansion of the innovatives class driving the evolution of cancer treatment
Strategic Perspectives: Lung Cancer - Cytotoxics Holding Steady While Innovatives Find a Niche
Pipeline Insight: Lung Cancer - Iressa Rises From the Ashes?
Cervical Cancer: Is Society Ready For a Preventative Answer?
Pipeline Insight: Angiogenesis Inhibitors. Diversification and expansion of the innovatives class driving the evolution of cancer treatment
Gastric Cancer Overview - Raising the Standard: Japanese Inspiration and a New Era of Giants
ECCO12 Highlights - Chemotherapies in Major Tumors
Pipeline Insight: Cancer Overview - Increasing Collaboration to Accommodate Increasing Fragmentation
Casodex 150mg - What now for AstraZeneca’s prostate cancer product?
Thrombosis in Cancer - Expanding Focus for Anticoagulants
Glioblastoma Review - Temodar partnering pipeline drugs
Oral Mucositis - Challenging the priorities of cancer therapy
Pipeline Insight: Tumor-targeted agents: Diversification and expansion of the innovatives class driving the evolution of cancer treatment
Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug Delivery Will Drive Market Opportunities
Strategic Perspectives: Non-Hodgkin’s Lymphoma\nA Market Galvanized by the Advent of Innovative Therapies
Neoadjuvant Therapy in Breast Cancer
Strategic Perspectives: Malignant Melanoma - Biotechnology-Driven Agents Finding a Flagship Indication?
Oncology Review 2002 - Biotechnology Niche Product Positioning Begins to Sharpen the Oncology Marketplace
Treatment Algorithms: Colorectal Cancer 5th Edition - New Gold Standards Emerge But Unmet Need Remains
Multiple Myeloma update with ASH highlights - Increasing the Therapeutic Option
Prostate Cancer Insight - Profiting From Changing Treatment Patterns
Bisphosphonates Update - The Treatment and Prevention of Bone Metastases in Breast and Prostate Cancer
Market Dynamics: Anti-hormonal Therapies - Positioning for a Changing Paradigm
Stakeholder Opinions: Ovarian Cancer - Beyond Carboplatin and Paclitaxel
Stakeholder Opinions: Renal Cell Carcinoma – A Gateway for Angiogenesis Inhibitors?
Lung Cancer - Third-Generation Cytotoxics Set to Dominate the Market
Commercial Perspectives: Anti-Hormonals - Tamoxifen to be Obsolete by 2010?
Cytotoxics - Third-Generation Cytotoxics To Offset Taxol’s Generic Woes
Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep?
Adult ADHD - Strattera Grows Up
Pharmaceutical Portfolio Management: Strategies to Deliver Corporate Success
Addressing Pharma’s R&D Productivity Crisis: Technological and Strategic Initiatives to Improve Core Drug Discovery Capabilities
European Market Entry Strategies: Impact of Regulations, Pricing, Reimbursement, Parallel Trade and Generics Post-Accession
Therapeutic Vaccines: Strong Innovation But Far Away From Capitalization
Therapeutic Antibodies: Capitalizing on the Fully Human Wave
Analytical CRM: new technologies for the pharmaceutical industry
Optimizing Promotional Alliances: Benchmarking Co-marketing and Co-promotion

Complete list of publishers:

BioPortfolio are seeking new titles and are open to suggestions from our Readers. If you would like BioPortfolio to publish a biotechnology related report please Email our Publications Department.